{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "17",
                "@timestamp": "2022-08-17T15:55:16.000016-04:00",
                "@year": "2022",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Thailand Science Research and Innovation Fund Chulalongkorn University",
                    "xocs:funding-id": "CUFRB65_hea(69)_132_23_62"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-id": "GCUGR1125642021M",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Khon Kaen University",
                    "xocs:funding-agency-acronym": "KKU",
                    "xocs:funding-agency": "Khon Kaen University",
                    "xocs:funding-id": "AS65102",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004071",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "King Mongkut's University of Technology Thonburi",
                    "xocs:funding-agency-acronym": "KMUTT",
                    "xocs:funding-agency": "King Mongkut's University of Technology Thonburi",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004705",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "PCA",
                    "xocs:funding-agency-acronym": "PCA",
                    "xocs:funding-agency": "Pancreatic Cancer Action",
                    "xocs:funding-id": [
                        {"$": "12.79 ± 1.39 nM"},
                        {"$": "17.45 ± 1.22 nM"},
                        {"$": "366.40 ± 3.27 nM"},
                        {"$": "7.78 ± 1.02 nM"},
                        {"$": "84\u201386"}
                    ],
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100008179",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-16T05:47:42.297953Z",
            "xocs:funding-text": [
                {"$": "This research is funded by Thailand Science Research and Innovation Fund Chulalongkorn University ( CU) (CUFRB65_hea(69)_132_23_62 ) (Fundamental Fund 2565, CU). D.T. thanks the 90 th Anniversary of Chulalongkorn University (CU) Fund (Ratchadaphiseksomphot Endowment Fund, GCUGR1125642021M), and the Potential Development in Research for Graduate student Project, Faculty of Science, CU. P.M. would like to acknowledge the financial support from Faculty of Medicine, Khon Kaen University , Thailand (Grant number AS65102 ). R.P.P. would like to acknowledge the financial support from King Mongkut's University of Technology Thonburi (Fundamental Fund: fiscal year 2022) and the Research Strengthening Project of the Faculty of Engineering."},
                {"$": "In the gas phase, among all studied drugs, van der Waals (vdW) interactions were the main forces stabilizing drug binding, which were approximately two to three-fold stronger than electrostatic attraction, in line with the previous studies on several small-molecule therapeutic kinase inhibitors such as lapatinib, icotinib, and olmutinib [ 79\u201381]. Among five studied drugs in complex with wild-type EGFR, erlotinib (ΔGbindcal = −14.10 ± 0.14 kcal/mol) and gefitinib (−11.89 ± 0.54 kcal/mol) showed higher binding affinity than the other drugs (−10.52 ± 0.56, −8.20 ± 0.19, and −6.17 ± 0.18 kcal/mol for afatinib, dacomitinib, and osimertinib, respectively). This finding is in good agreement with the reported data showing that erlotinib and gefitinib are effective as the first-line treatment for patients with wild-type EGFR [82,83]. By considering the L858R/T790M EGFR double mutation, the ΔGbindcal values were ranked in the order of osimertinib (−11.29 ± 0.63 kcal/mol) < afatinib (−10.35 ± 0.89 kcal/mol) < dacomitinib (−10.22 ± 0.22 kcal/mol) < erlotinib (−9.72 ± 0.87 kcal/mol) < gefitinib (−6.51 ± 0.11 kcal/mol), suggesting that osimertinib exhibited high binding efficiency towards L858R/T790M EGFR. Similarly, the ΔGbindcal of all the studied inhibitors against L858R/T790M/C797S triple mutated EGFR was ranked in the order of osimertinib (−14.18 ± 0.77 kcal/mol) < afatinib (−9.76 ± 0.66 kcal/mol) < dacomitinib (−6.55 ± 0.89 kcal/mol) < erlotinib (−2.51 ± 0.87 kcal/mol) < gefitinib (−2.15 ± 0.75 kcal/mol). These finding are strongly supported by PCA results showing that the molecular complexation of osimertinib against the two mutated EGFRs was in a closed conformation, whereas that against wild-type EGFR was in an open conformation. This might be one of the reasons why osimertinib exhibits minimal effect on wild-type EGFR [ 46\u201349, 84\u201386]. Moreover, the kinase inhibitory activity of the studied drugs against EGFRs was evaluated to support the free energy calculations based on MM/PBSA method. We found that the IC50 values in this study (Fig. 4) were similar to those from previous works (Table S1). For wild-type EGFR, erlotinib gave the IC50 value (13.55 ± 0.80 nM) close to gefitinib (17.45 ± 1.22 nM), whilst osimertinib gave the highest IC50 value (366.40 ± 3.27 nM). For mutated EGFRs, osimertinib showed the lowest IC50 value for both L858R/T790M (12.79 ± 1.39 nM) and L858R/T790M/C797S (7.78 ± 1.02 nM) EGFRs. The obtained information suggested that osimertinib is a potent inhibitor against double and triple mutated EGFRs.In addition, the number of native atom contacts within 3.5 Å of ligand during the last 100 ns was calculated (Fig. 9B). For wild-type EGFR, the number of atom contacts of erlotinib was somewhat higher than that of the other drugs, in good agreement with the lower water accessibility and the higher number of H-bond formations mentioned above. In the case of L858R/T790M double mutation, osimertinib displayed the highest number of atom contacts, followed by afatinib, dacomtinib, erlotinib, and gefitinib, respectively. In the triple mutation system, the number of atom contacts of almost studied ligands was decreased; however, osimertinib still showed the highest atom contacts. Altogether, the number of atom contacts consistently supported MM/PBSA calculations and SASA values information mentioned above.This research is funded by Thailand Science Research and Innovation Fund Chulalongkorn University (CU) (CUFRB65_hea(69)_132_23_62) (Fundamental Fund 2565, CU). D.T. thanks the 90th Anniversary of Chulalongkorn University (CU) Fund (Ratchadaphiseksomphot Endowment Fund, GCUGR1125642021M), and the Potential Development in Research for Graduate student Project, Faculty of Science, CU. P.M. would like to acknowledge the financial support from Faculty of Medicine, Khon Kaen University, Thailand (Grant number AS65102). R.P.P. would like to acknowledge the financial support from King Mongkut's University of Technology Thonburi (Fundamental Fund: fiscal year 2022) and the Research Strengthening Project of the Faculty of Engineering."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Biocatalyst and Sustainable Biotechnology"},
                                {"$": "Department of Biochemistry"},
                                {"$": "Faculty of Science"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "112978483"
                            },
                            "@affiliation-instance-id": "S0010482522005546-54dc8b4a05ca65083353087276697ed9",
                            "ce:source-text": "Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand",
                            "@dptid": "112978483"
                        },
                        "author": [
                            {
                                "ce:given-name": "Duangjai",
                                "preferred-name": {
                                    "ce:given-name": "Duangjai",
                                    "ce:initials": "D.",
                                    "ce:surname": "Todsaporn",
                                    "ce:indexed-name": "Todsaporn D."
                                },
                                "@author-instance-id": "S0010482522005546-344e00ed786e702a93a4044d07ffc5b4",
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Todsaporn",
                                "@auid": "57734251200",
                                "ce:indexed-name": "Todsaporn D."
                            },
                            {
                                "ce:given-name": "Thanyada",
                                "preferred-name": {
                                    "ce:given-name": "Thanyada",
                                    "ce:initials": "T.",
                                    "ce:surname": "Rungrotmongkol",
                                    "ce:indexed-name": "Rungrotmongkol T."
                                },
                                "@author-instance-id": "S0010482522005546-c9ed322f0baff1abb6cf73ab1a650b19",
                                "@seq": "5",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Rungrotmongkol",
                                "@auid": "6507384130",
                                "ce:indexed-name": "Rungrotmongkol T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "40002",
                            "@afid": "60026046",
                            "@country": "tha",
                            "city": "Khon Kaen",
                            "organization": [
                                {"$": "Department of Biochemistry"},
                                {"$": "and Center for Translational Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Khon Kaen University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60026046",
                                    "@dptid": "104325075"
                                },
                                {"@afid": "60017165"}
                            ],
                            "@affiliation-instance-id": "S0010482522005546-a62d5b94244ddeae96317fa12eab58bd",
                            "ce:source-text": "Department of Biochemistry, Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand",
                            "@dptid": "104325075"
                        },
                        "author": [{
                            "ce:given-name": "Panupong",
                            "preferred-name": {
                                "ce:given-name": "Panupong",
                                "ce:initials": "P.",
                                "ce:surname": "Mahalapbutr",
                                "ce:indexed-name": "Mahalapbutr P."
                            },
                            "@author-instance-id": "S0010482522005546-b78f42dd25a63fa5d5a2aa8463e1eb6d",
                            "@seq": "2",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mahalapbutr",
                            "@auid": "57196032669",
                            "ce:indexed-name": "Mahalapbutr P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60008786",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Biological Engineering Program"},
                                {"$": "Faculty of Engineering"},
                                {"$": "King Mongkut's University of Technology Thonburi"}
                            ],
                            "affiliation-id": {
                                "@afid": "60008786",
                                "@dptid": "106278735"
                            },
                            "@affiliation-instance-id": "S0010482522005546-ac55d6dca7125569f3ba57a8cbed6567",
                            "ce:source-text": "Biological Engineering Program, Faculty of Engineering, King Mongkut's University of Technology Thonburi, Bangkok, Thailand",
                            "@dptid": "106278735"
                        },
                        "author": [{
                            "ce:given-name": "Rungtiva P.",
                            "preferred-name": {
                                "ce:given-name": "Rungtiva P.",
                                "ce:initials": "R.P.",
                                "ce:surname": "Poo-arporn",
                                "ce:indexed-name": "Poo-arporn R.P."
                            },
                            "@author-instance-id": "S0010482522005546-f04a20d8585838c4e2cc1d37b3734f3a",
                            "@seq": "3",
                            "ce:initials": "R.P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Poo-arporn",
                            "@auid": "57191282184",
                            "@orcid": "0000-0002-2584-9890",
                            "ce:indexed-name": "Poo-arporn R.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10900",
                            "@afid": "60021944",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Biochemistry"},
                                {"$": "Faculty of Science"},
                                {"$": "Kasetsart University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60021944",
                                "@dptid": "104123263"
                            },
                            "@affiliation-instance-id": "S0010482522005546-b216e596dd8357566da49be64889c29a",
                            "ce:source-text": "Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand",
                            "@dptid": "104123263"
                        },
                        "author": [{
                            "ce:given-name": "Kiattawee",
                            "preferred-name": {
                                "ce:given-name": "Kiattawee",
                                "ce:initials": "K.",
                                "ce:surname": "Choowongkomon",
                                "ce:indexed-name": "Choowongkomon K."
                            },
                            "@author-instance-id": "S0010482522005546-0746cb64387840b1bff96c8e35aca87d",
                            "@seq": "4",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Choowongkomon",
                            "@auid": "6506273203",
                            "@orcid": "0000-0002-2421-7859",
                            "ce:indexed-name": "Choowongkomon K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Program in Bioinformatics and Computational Biology"},
                                {"$": "Graduate School"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "122727284"
                            },
                            "@affiliation-instance-id": "S0010482522005546-ee20b33e284d72b5319a740005e88770",
                            "ce:source-text": "Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, 10330, Thailand",
                            "@dptid": "122727284"
                        },
                        "author": [{
                            "ce:given-name": "Thanyada",
                            "preferred-name": {
                                "ce:given-name": "Thanyada",
                                "ce:initials": "T.",
                                "ce:surname": "Rungrotmongkol",
                                "ce:indexed-name": "Rungrotmongkol T."
                            },
                            "@author-instance-id": "S0010482522005546-c9ed322f0baff1abb6cf73ab1a650b19",
                            "@seq": "5",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rungrotmongkol",
                            "@auid": "6507384130",
                            "ce:indexed-name": "Rungrotmongkol T."
                        }]
                    }
                ],
                "citation-title": "Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR",
                "abstracts": "© 2022Mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR), including L858R/T790M double and L858R/T790M/C797S triple mutations, are major causes of acquired resistance towards EGFR targeted drugs. In this work, a combination of comprehensive molecular modeling and in vitro kinase inhibition assay was used to unravel the mutational effects of EGFR on the susceptibility of three generations of EGFR tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib, dacomitinib, and osimertinib) in comparison with the wild-type EGFR. The binding affinity of all studied inhibitors towards the double and triple EGFR mutations was in good agreement with the experimental data, ranked in the order of osimertinib > afatinib > dacomitinib > erlotinib > gefitinib. Three hot-spot residues at the hinge region (M790, M793, and C797) were involved in the binding of osimertinib and afatinib, enhancing their inhibitory activity towards mutated EGFRs. Both double and triple EGFR mutations causing erlotinib and gefitinib resistance are mainly caused by the low number of H-bond occupations, the low number of surrounding atoms, and the high number of water molecules accessible to the enzyme active site. According to principal component analysis, the molecular complexation of osimertinib against the two mutated EGFRs was in a closed conformation, whereas that against wild-type EGFR was in an open conformation, resulting in drug resistance. This work paves the way for further design of the novel EGFR inhibitors to overcome drug resistance mechanisms.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "40002",
                        "@country": "tha",
                        "city": "Khon Kaen",
                        "organization": [
                            {"$": "Department of Biochemistry"},
                            {"$": "and Center for Translational Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Khon Kaen University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Panupong",
                        "ce:initials": "P.",
                        "ce:surname": "Mahalapbutr",
                        "ce:indexed-name": "Mahalapbutr P."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Drug resistance",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "EGFR inhibitor",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Kinase inhibition",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Molecular dynamics simulation",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.elsevier.com/locate/compbiomed",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Computers in Biology and Medicine",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {"@volume": "147"}},
                    "@type": "j",
                    "sourcetitle": "Computers in Biology and Medicine",
                    "publicationdate": {
                        "month": "08",
                        "year": "2022",
                        "date-text": "August 2022",
                        "day": "01"
                    },
                    "codencode": "CBMDA",
                    "sourcetitle-abbrev": "Comput. Biol. Med.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "18790534",
                            "@type": "electronic"
                        },
                        {
                            "$": "00104825",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Elsevier Ltd"},
                    "article-number": "105787",
                    "@srcid": "17957"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CPXCLASS",
                            "classification": [
                                {
                                    "classification-code": "408",
                                    "classification-description": "Structural Design"
                                },
                                {
                                    "classification-code": "801.4",
                                    "classification-description": "Physical Chemistry"
                                },
                                {
                                    "classification-code": "804.1",
                                    "classification-description": "Organic Compounds"
                                },
                                {
                                    "classification-code": "922.2",
                                    "classification-description": "Mathematical Statistics"
                                },
                                {
                                    "classification-code": "931.3",
                                    "classification-description": "Atomic and Molecular Physics"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "FLXCLASS",
                            "classification": {
                                "classification-code": "902",
                                "classification-description": "FLUIDEX; Related Topics"
                            }
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "1706"},
                                {"$": "2718"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "COMP"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "439081-18-2"},
                                        {"$": "850140-72-6"},
                                        {"$": "850140-73-7"}
                                    ],
                                    "chemical-name": "afatinib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1110813-31-4"},
                                        {"$": "1042385-75-0"}
                                    ],
                                    "chemical-name": "dacomitinib"
                                },
                                {
                                    "cas-registry-number": "79079-06-4",
                                    "chemical-name": "epidermal growth factor receptor"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "183319-69-9"},
                                        {"$": "183321-74-6"}
                                    ],
                                    "chemical-name": "erlotinib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "184475-35-2"},
                                        {"$": "184475-55-6"},
                                        {"$": "184475-56-7"}
                                    ],
                                    "chemical-name": "gefitinib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1421373-65-0"},
                                        {"$": "1421373-66-1"}
                                    ],
                                    "chemical-name": "osimertinib"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Afatinib"},
                                {"chemical-name": "EGFR protein, human"},
                                {"chemical-name": "ErbB Receptors"},
                                {"chemical-name": "Erlotinib Hydrochloride"},
                                {"chemical-name": "Gefitinib"},
                                {"chemical-name": "Protein Kinase Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "In the gas phase, among all studied drugs, van der Waals (vdW) interactions were the main forces stabilizing drug binding, which were approximately two to three-fold stronger than electrostatic attraction, in line with the previous studies on several small-molecule therapeutic kinase inhibitors such as lapatinib, icotinib, and olmutinib [ 79\u201381]. Among five studied drugs in complex with wild-type EGFR, erlotinib (ΔGbindcal= −14.10 ± 0.14 kcal/mol) and gefitinib (−11.89 ± 0.54 kcal/mol) showed higher binding affinity than the other drugs (−10.52 ± 0.56, −8.20 ± 0.19, and −6.17 ± 0.18 kcal/mol for afatinib, dacomitinib, and osimertinib, respectively). This finding is in good agreement with the reported data showing that erlotinib and gefitinib are effective as the first-line treatment for patients with wild-type EGFR [82,83]. By considering the L858R/T790M EGFR double mutation, the ΔGbindcalvalues were ranked in the order of osimertinib (−11.29 ± 0.63 kcal/mol) < afatinib (−10.35 ± 0.89 kcal/mol) < dacomitinib (−10.22 ± 0.22 kcal/mol) < erlotinib (−9.72 ± 0.87 kcal/mol) < gefitinib (−6.51 ± 0.11 kcal/mol), suggesting that osimertinib exhibited high binding efficiency towards L858R/T790M EGFR. Similarly, the ΔGbindcalof all the studied inhibitors against L858R/T790M/C797S triple mutated EGFR was ranked in the order of osimertinib (−14.18 ± 0.77 kcal/mol) < afatinib (−9.76 ± 0.66 kcal/mol) < dacomitinib (−6.55 ± 0.89 kcal/mol) < erlotinib (−2.51 ± 0.87 kcal/mol) < gefitinib (−2.15 ± 0.75 kcal/mol). These finding are strongly supported by PCA results showing that the molecular complexation of osimertinib against the two mutated EGFRs was in a closed conformation, whereas that against wild-type EGFR was in an open conformation. This might be one of the reasons why osimertinib exhibits minimal effect on wild-type EGFR [ 46\u201349, 84\u201386]. Moreover, the kinase inhibitory activity of the studied drugs against EGFRs was evaluated to support the free energy calculations based on MM/PBSA method. We found that the IC50values in this study (Fig. 4) were similar to those from previous works (Table S1). For wild-type EGFR, erlotinib gave the IC50value (13.55 ± 0.80 nM) close to gefitinib (17.45 ± 1.22 nM), whilst osimertinib gave the highest IC50value (366.40 ± 3.27 nM). For mutated EGFRs, osimertinib showed the lowest IC50value for both L858R/T790M (12.79 ± 1.39 nM) and L858R/T790M/C797S (7.78 ± 1.02 nM) EGFRs. The obtained information suggested that osimertinib is a potent inhibitor against double and triple mutated EGFRs.In addition, the number of native atom contacts within 3.5 Å of ligand during the last 100 ns was calculated (Fig. 9B). For wild-type EGFR, the number of atom contacts of erlotinib was somewhat higher than that of the other drugs, in good agreement with the lower water accessibility and the higher number of H-bond formations mentioned above. In the case of L858R/T790M double mutation, osimertinib displayed the highest number of atom contacts, followed by afatinib, dacomtinib, erlotinib, and gefitinib, respectively. In the triple mutation system, the number of atom contacts of almost studied ligands was decreased; however, osimertinib still showed the highest atom contacts. Altogether, the number of atom contacts consistently supported MM/PBSA calculations and SASA values information mentioned above.This research is funded by Thailand Science Research and Innovation Fund Chulalongkorn University (CU) (CUFRB65_hea(69)_132_23_62) (Fundamental Fund 2565, CU). D.T. thanks the 90th Anniversary of Chulalongkorn University (CU) Fund (Ratchadaphiseksomphot Endowment Fund, GCUGR1125642021M), and the Potential Development in Research for Graduate student Project, Faculty of Science, CU. P.M. would like to acknowledge the financial support from Faculty of Medicine, Khon Kaen University, Thailand (Grant number AS65102). R.P.P. would like to acknowledge the financial support from King Mongkut's University of Technology Thonburi (Fundamental Fund: fiscal year 2022) and the Research Strengthening Project of the Faculty of Engineering.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "KMUTT",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "King Mongkut's University of Technology Thonburi"
                            },
                            "grant-agency-id": "501100004705"
                        },
                        {
                            "grant-acronym": "TSRI",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Thailand Science Research and Innovation"
                            },
                            "grant-agency-id": "501100017170"
                        },
                        {
                            "grant-id": "AS65102",
                            "grant-acronym": "KKU",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Khon Kaen University"
                            },
                            "grant-agency-id": "501100004071"
                        },
                        {
                            "grant-id": "CU) (CUFRB65_hea(69)_132_23_62",
                            "grant-acronym": "CU",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Chulalongkorn University"
                            },
                            "grant-agency-id": "501100002873"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "CPX"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "16",
                    "@timestamp": "BST 03:30:05",
                    "@year": "2022",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2019111392",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "941328993",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20222712328670",
                            "@idtype": "CPX"
                        },
                        {
                            "$": "20220608736",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "35803080",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2022288359",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20222056752",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2022310451",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20222319204",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85133449449",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85133449449",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "638438169",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76289099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0010482522005546",
                    "ce:ern": "pii:S0010482522005546",
                    "ce:doi": "10.1016/j.compbiomed.2022.105787"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "105",
                "reference": [
                    {
                        "ref-fulltext": "Zhang, H., Osimertinib making a breakthrough in lung cancer targeted therapy. OncoTargets Ther., 9, 2016, 5489.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Osimertinib making a breakthrough in lung cancer targeted therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84988733192",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "5489"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang H."
                            }]},
                            "ref-sourcetitle": "OncoTargets Ther."
                        },
                        "ce:source-text": "Zhang, H., Osimertinib making a breakthrough in lung cancer targeted therapy. OncoTargets Ther., 2016. 9: p. 5489."
                    },
                    {
                        "ref-fulltext": "Bethune, G., et al. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J. Thorac. Dis., 2(1), 2010, 48.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80255135963",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "48"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Bethune",
                                    "ce:indexed-name": "Bethune G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Dis."
                        },
                        "ce:source-text": "Bethune, G., et al., Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J. Thorac. Dis., 2010. 2(1): p. 48."
                    },
                    {
                        "ref-fulltext": "Li, X., et al. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway. Pharmacol. Res. 115 (2017), 45\u201355.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84996940121",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "115"},
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "55"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li X."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacol. Res."
                        },
                        "ce:source-text": "Li, X., et al., Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway. Pharmacol. Res., 2017. 115: p. 45-55."
                    },
                    {
                        "ref-fulltext": "Engel, J., et al. Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach. J. Med. Chem. 58:17 (2015), 6844\u20136863.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941585574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "58",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "6844",
                                    "@last": "6863"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Engel",
                                    "ce:indexed-name": "Engel J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Med. Chem."
                        },
                        "ce:source-text": "Engel, J., et al., Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach. J. Med. Chem., 2015. 58(17): p. 6844-6863."
                    },
                    {
                        "ref-fulltext": "Peters, S., Zimmermann, S., Adjei, A.A., Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug\u2013drug interactions. Cancer Treat Rev. 40:8 (2014), 917\u2013926.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug\u2013drug interactions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84904810695",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "917",
                                    "@last": "926"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Peters",
                                    "ce:indexed-name": "Peters S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Zimmermann",
                                    "ce:indexed-name": "Zimmermann S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Adjei",
                                    "ce:indexed-name": "Adjei A.A."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Treat Rev."
                        },
                        "ce:source-text": "Peters, S., S. Zimmermann, and A.A. Adjei, Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions. Cancer Treat Rev., 2014. 40(8): p. 917-926."
                    },
                    {
                        "ref-fulltext": "Oda, K., et al. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol., 1(1), 2005 2005.0010.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "A comprehensive pathway map of epidermal growth factor receptor signaling"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33746889808",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "1",
                                "@issue": "1"
                            }},
                            "ref-text": "2005.0010",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Oda",
                                    "ce:indexed-name": "Oda K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol. Syst. Biol."
                        },
                        "ce:source-text": "Oda, K., et al., A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol., 2005. 1(1): p. 2005.0010."
                    },
                    {
                        "ref-fulltext": "Yarden, Y., Sliwkowski, M.X., Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:2 (2001), 127\u2013137.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Untangling the ErbB signalling network"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035256698",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "127",
                                    "@last": "137"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yarden",
                                    "ce:indexed-name": "Yarden Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Sliwkowski",
                                    "ce:indexed-name": "Sliwkowski M.X."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Mol. Cell Biol."
                        },
                        "ce:source-text": "Yarden, Y. and M.X. Sliwkowski, Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol., 2001. 2(2): p. 127-137."
                    },
                    {
                        "ref-fulltext": "Datta, S.R., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:2 (1997), 231\u2013241.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0030702123",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "91",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "231",
                                    "@last": "241"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Datta",
                                    "ce:indexed-name": "Datta S.R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Datta, S.R., et al., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 1997. 91(2): p. 231-241."
                    },
                    {
                        "ref-fulltext": "Chen, P., et al. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol. 127:3 (1994), 847\u2013857.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1994"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0028089832",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "127",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "847",
                                    "@last": "857"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Cell Biol."
                        },
                        "ce:source-text": "Chen, P., et al., Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol., 1994. 127(3): p. 847-857."
                    },
                    {
                        "ref-fulltext": "Kharitonenkov, A., et al. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:6621 (1997), 181\u2013186.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "A family of proteins that inhibit signalling through tyrosine kinase receptors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0030893120",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "386",
                                    "@issue": "6621"
                                },
                                "pagerange": {
                                    "@first": "181",
                                    "@last": "186"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kharitonenkov",
                                    "ce:indexed-name": "Kharitonenkov A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Kharitonenkov, A., et al., A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature, 1997. 386(6621): p. 181-186."
                    },
                    {
                        "ref-fulltext": "Sternberg, M.J., Gullick, W.J., A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. Protein Eng. Des. Sel. 3:4 (1990), 245\u2013248.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1990"},
                            "ref-title": {"ref-titletext": "A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0025274249",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "245",
                                    "@last": "248"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sternberg",
                                    "ce:indexed-name": "Sternberg M.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Gullick",
                                    "ce:indexed-name": "Gullick W.J."
                                }
                            ]},
                            "ref-sourcetitle": "Protein Eng. Des. Sel."
                        },
                        "ce:source-text": "Sternberg, M.J. and W.J. Gullick, A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. Protein Eng. Des. Sel., 1990. 3(4): p. 245-248."
                    },
                    {
                        "ref-fulltext": "Normanno, N., et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366:1 (2006), 2\u201316.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor (EGFR) signaling in cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "32044464123",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "366",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "2",
                                    "@last": "16"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Normanno",
                                    "ce:indexed-name": "Normanno N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gene"
                        },
                        "ce:source-text": "Normanno, N., et al., Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 2006. 366(1): p. 2-16."
                    },
                    {
                        "ref-fulltext": "Torre, L.A., et al. Global cancer statistics, 2012. CA A Cancer J. Clin. 65:2 (2015), 87\u2013108.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Global cancer statistics, 2012"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84924271853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "87",
                                    "@last": "108"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Torre",
                                    "ce:indexed-name": "Torre L.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA A Cancer J. Clin."
                        },
                        "ce:source-text": "Torre, L.A., et al., Global cancer statistics, 2012. CA A Cancer J. Clin., 2015. 65(2): p. 87-108."
                    },
                    {
                        "ref-fulltext": "Perez, E.A., The role of adjuvant monoclonal antibody therapy for breast cancer: rationale and new studies. Curr. Oncol. Rep. 3:6 (2001), 516\u2013522.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "The role of adjuvant monoclonal antibody therapy for breast cancer: rationale and new studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035514398",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "516",
                                    "@last": "522"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "E.A.",
                                "@_fa": "true",
                                "ce:surname": "Perez",
                                "ce:indexed-name": "Perez E.A."
                            }]},
                            "ref-sourcetitle": "Curr. Oncol. Rep."
                        },
                        "ce:source-text": "Perez, E.A., The role of adjuvant monoclonal antibody therapy for breast cancer: rationale and new studies. Curr. Oncol. Rep., 2001. 3(6): p. 516-522."
                    },
                    {
                        "ref-fulltext": "Wang, X., et al. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin. Cancer Res. 13:3 (2007), 953\u2013957.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33847349721",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "953",
                                    "@last": "957"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang X."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Wang, X., et al., Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin. Cancer Res., 2007. 13(3): p. 953-957."
                    },
                    {
                        "ref-fulltext": "Shia, J., et al. Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod. Pathol. 18:10 (2005), 1350\u20131356.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "25144491785",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1350",
                                    "@last": "1356"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Shia",
                                    "ce:indexed-name": "Shia J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mod. Pathol."
                        },
                        "ce:source-text": "Shia, J., et al., Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod. Pathol., 2005. 18(10): p. 1350-1356."
                    },
                    {
                        "ref-fulltext": "Shepherd, F.A., et al. Erlotinib in previously treated non\u2013small-cell lung cancer. N. Engl. J. Med. 353:2 (2005), 123\u2013132.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Erlotinib in previously treated non\u2013small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "22044445517",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "353",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "123",
                                    "@last": "132"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Shepherd",
                                    "ce:indexed-name": "Shepherd F.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Shepherd, F.A., et al., Erlotinib in previously treated non-small-cell lung cancer. N. Engl. J. Med., 2005. 353(2): p. 123-132."
                    },
                    {
                        "ref-fulltext": "Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA A Cancer J. Clin. 65:1 (2015), 5\u201329.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer statistics, 2015"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920837701",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "5",
                                    "@last": "29"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel R.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Miller",
                                    "ce:indexed-name": "Miller K.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA A Cancer J. Clin."
                        },
                        "ce:source-text": "Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2015. CA A Cancer J. Clin., 2015. 65(1): p. 5-29."
                    },
                    {
                        "ref-fulltext": "Sogabe, S., et al. Structure-based approach for the discovery of pyrrolo [3, 2-d] pyrimidine-based EGFR T790M/L858R mutant inhibitors. ACS Med. Chem. Lett. 4:2 (2013), 201\u2013205.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Structure-based approach for the discovery of pyrrolo [3, 2-d] pyrimidine-based EGFR T790M/L858R mutant inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84873973328",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "201",
                                    "@last": "205"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Sogabe",
                                    "ce:indexed-name": "Sogabe S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ACS Med. Chem. Lett."
                        },
                        "ce:source-text": "Sogabe, S., et al., Structure-based approach for the discovery of pyrrolo [3, 2-d] pyrimidine-based EGFR T790M/L858R mutant inhibitors. ACS Med. Chem. Lett., 2013. 4(2): p. 201-205."
                    },
                    {
                        "ref-fulltext": "Siegel, R., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA A Cancer J. Clin. 61:4 (2011), 212\u2013236.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80051580618",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "61",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "212",
                                    "@last": "236"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA A Cancer J. Clin."
                        },
                        "ce:source-text": "Siegel, R., et al., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA A Cancer J. Clin., 2011. 61(4): p. 212-236."
                    },
                    {
                        "ref-fulltext": "Pérez-Soler, R., et al. Determinants of tumor response and survival with erlotinib in patients with non\u2014small-cell lung cancer. J. Clin. Oncol. 22:16 (2004), 3238\u20133247.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Determinants of tumor response and survival with erlotinib in patients with non\u2014small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "4344646459",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "3238",
                                    "@last": "3247"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Pérez-Soler",
                                    "ce:indexed-name": "Perez-Soler R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Perez-Soler, R., et al., Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J. Clin. Oncol., 2004. 22(16): p. 3238-3247."
                    },
                    {
                        "ref-fulltext": "Kris, M.G., et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non\u2013small cell lung cancer: a randomized trial. JAMA 290:16 (2003), 2149\u20132158.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non\u2013small cell lung cancer: a randomized trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0142055937",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "290",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "2149",
                                    "@last": "2158"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Kris",
                                    "ce:indexed-name": "Kris M.G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Kris, M.G., et al., Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA, 2003. 290(16): p. 2149-2158."
                    },
                    {
                        "ref-fulltext": "Wang, A., et al. Discovery of (R)-1-(3-(4-amino-3-(3-chloro-4-(pyridin-2-ylmethoxy) phenyl)-1 H-pyrazolo [3, 4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en-1-one (CHMFL-EGFR-202) as a novel irreversible EGFR mutant kinase inhibitor with a distinct binding mode. J. Med. Chem. 60:7 (2017), 2944\u20132962.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Discovery of (R)-1-(3-(4-amino-3-(3-chloro-4-(pyridin-2-ylmethoxy) phenyl)-1 H-pyrazolo [3, 4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en-1-one (CHMFL-EGFR-202) as a novel irreversible EGFR mutant kinase inhibitor with a distinct binding mode"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017529488",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "60",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "2944",
                                    "@last": "2962"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Med. Chem."
                        },
                        "ce:source-text": "Wang, A., et al., Discovery of (R)-1-(3-(4-amino-3-(3-chloro-4-(pyridin-2-ylmethoxy) phenyl)-1 H-pyrazolo [3, 4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en-1-one (CHMFL-EGFR-202) as a novel irreversible EGFR mutant kinase inhibitor with a distinct binding mode. J. Med. Chem., 2017. 60(7): p. 2944-2962."
                    },
                    {
                        "ref-fulltext": "Mitsudomi, T., et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 11:2 (2010), 121\u2013128.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "75249087060",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "128"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Mitsudomi",
                                    "ce:indexed-name": "Mitsudomi T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Mitsudomi, T., et al., Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol., 2010. 11(2): p. 121-128."
                    },
                    {
                        "ref-fulltext": "Cataldo, V.D., et al. Treatment of non\u2013small-cell lung cancer with erlotinib or gefitinib. N. Engl. J. Med. 364:10 (2011), 947\u2013955.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Treatment of non\u2013small-cell lung cancer with erlotinib or gefitinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79952376771",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "364",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "947",
                                    "@last": "955"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "V.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Cataldo",
                                    "ce:indexed-name": "Cataldo V.D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Cataldo, V.D., et al., Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N. Engl. J. Med., 2011. 364(10): p. 947-955."
                    },
                    {
                        "ref-fulltext": "Capoferri, L., et al. Quantum mechanics/molecular mechanics modeling of covalent addition between EGFR\u2013cysteine 797 and N-(4-anilinoquinazolin-6-yl) acrylamide. J. Chem. Inf. Model. 55:3 (2015), 589\u2013599.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Quantum mechanics/molecular mechanics modeling of covalent addition between EGFR\u2013cysteine 797 and N-(4-anilinoquinazolin-6-yl) acrylamide"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925452326",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "55",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "589",
                                    "@last": "599"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Capoferri",
                                    "ce:indexed-name": "Capoferri L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Chem. Inf. Model."
                        },
                        "ce:source-text": "Capoferri, L., et al., Quantum mechanics/molecular mechanics modeling of covalent addition between EGFR-cysteine 797 and N-(4-anilinoquinazolin-6-yl) acrylamide. J. Chem. Inf. Model., 2015. 55(3): p. 589-599."
                    },
                    {
                        "ref-fulltext": "Kobayashi, S., et al. EGFR mutation and resistance of non\u2013small-cell lung cancer to gefitinib. N. Engl. J. Med. 352:8 (2005), 786\u2013792.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "EGFR mutation and resistance of non\u2013small-cell lung cancer to gefitinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "13844317894",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "352",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "786",
                                    "@last": "792"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kobayashi",
                                    "ce:indexed-name": "Kobayashi S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Kobayashi, S., et al., EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med., 2005. 352(8): p. 786-792."
                    },
                    {
                        "ref-fulltext": "Cheng, H., Planken, S., Precedence and Promise of Covalent Inhibitors of EGFR and KRAS for Patients with Non-small-cell Lung Cancer. 2018, ACS Publications.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Precedence and Promise of Covalent Inhibitors of EGFR and KRAS for Patients with Non-small-cell Lung Cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85133444306",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "ACS Publications",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheng",
                                    "ce:indexed-name": "Cheng H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Planken",
                                    "ce:indexed-name": "Planken S."
                                }
                            ]}
                        },
                        "ce:source-text": "Cheng, H. and S. Planken, Precedence and Promise of Covalent Inhibitors of EGFR and KRAS for Patients with Non-small-cell Lung Cancer. 2018, ACS Publications."
                    },
                    {
                        "ref-fulltext": "Michalczyk, A., et al. Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR pp 3482\u20133488. Bioorg. Med. Chem., 16(7), 2008.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR pp 3482\u20133488"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "41649099467",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "16",
                                "@issue": "7"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Michalczyk",
                                    "ce:indexed-name": "Michalczyk A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bioorg. Med. Chem."
                        },
                        "ce:source-text": "Michalczyk, A., et al., Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR pp 3482-3488. Bioorg. Med. Chem., 2008. 16(7)."
                    },
                    {
                        "ref-fulltext": "Sos, M.L., et al. Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation. Cancer Res. 70:3 (2010), 868\u2013874.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "76249108622",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "70",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "868",
                                    "@last": "874"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Sos",
                                    "ce:indexed-name": "Sos M.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Sos, M.L., et al., Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation. Cancer Res., 2010. 70(3): p. 868-874."
                    },
                    {
                        "ref-fulltext": "Klüter, S., et al. Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance. Chembiochem 11:18 (2010), 2557\u20132566.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78650013505",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "2557",
                                    "@last": "2566"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Klüter",
                                    "ce:indexed-name": "Kluter S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Chembiochem"
                        },
                        "ce:source-text": "Kluter, S., et al., Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance. Chembiochem, 2010. 11(18): p. 2557-2566."
                    },
                    {
                        "ref-fulltext": "Li, Q., et al. Discovery of potent and noncovalent reversible EGFR kinase inhibitors of EGFRL858R/T790M/C797S. ACS Med. Chem. Lett. 10:6 (2019), 869\u2013873.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Discovery of potent and noncovalent reversible EGFR kinase inhibitors of EGFRL858R/T790M/C797S"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066492919",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "869",
                                    "@last": "873"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Q.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li Q."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ACS Med. Chem. Lett."
                        },
                        "ce:source-text": "Li, Q., et al., Discovery of potent and noncovalent reversible EGFR kinase inhibitors of EGFRL858R/T790M/C797S. ACS Med. Chem. Lett., 2019. 10(6): p. 869-873."
                    },
                    {
                        "ref-fulltext": "Engelman, J.A., et al. PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Cancer Res. 67:24 (2007), 11924\u201311932.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "37549061078",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "67",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "11924",
                                    "@last": "11932"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Engelman",
                                    "ce:indexed-name": "Engelman J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Engelman, J.A., et al., PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Cancer Res., 2007. 67(24): p. 11924-11932."
                    },
                    {
                        "ref-fulltext": "Zhou, W., et al. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature 462:7276 (2009), 1070\u20131074.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Novel mutant-selective EGFR kinase inhibitors against EGFR T790M"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "72949092456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "462",
                                    "@issue": "7276"
                                },
                                "pagerange": {
                                    "@first": "1070",
                                    "@last": "1074"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Zhou, W., et al., Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature, 2009. 462(7276): p. 1070-1074."
                    },
                    {
                        "ref-fulltext": "Heuckmann, J.M., Rauh, D., Thomas, R.K., Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 30:27 (2012), 3417\u20133420.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866756037",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "27"
                                },
                                "pagerange": {
                                    "@first": "3417",
                                    "@last": "3420"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Heuckmann",
                                    "ce:indexed-name": "Heuckmann J.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Rauh",
                                    "ce:indexed-name": "Rauh D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Thomas",
                                    "ce:indexed-name": "Thomas R.K."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."
                        },
                        "ce:source-text": "Heuckmann, J.M., D. Rauh, and R.K. Thomas, Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 2012. 30(27): p. 3417-3420."
                    },
                    {
                        "ref-fulltext": "Kalgutkar, A.S., Dalvie, D.K., Drug discovery for a new generation of covalent drugs. Expet Opin. Drug Discov. 7:7 (2012), 561\u2013581.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Drug discovery for a new generation of covalent drugs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84862877720",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "561",
                                    "@last": "581"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kalgutkar",
                                    "ce:indexed-name": "Kalgutkar A.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Dalvie",
                                    "ce:indexed-name": "Dalvie D.K."
                                }
                            ]},
                            "ref-sourcetitle": "Expet Opin. Drug Discov."
                        },
                        "ce:source-text": "Kalgutkar, A.S. and D.K. Dalvie, Drug discovery for a new generation of covalent drugs. Expet Opin. Drug Discov., 2012. 7(7): p. 561-581."
                    },
                    {
                        "ref-fulltext": "Copeland, R.A., Pompliano, D.L., Meek, T.D., Drug\u2013target residence time and its implications for lead optimization. Nat. Rev. Drug Discov. 5:9 (2006), 730\u2013739.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Drug\u2013target residence time and its implications for lead optimization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33748325882",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "730",
                                    "@last": "739"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Copeland",
                                    "ce:indexed-name": "Copeland R.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Pompliano",
                                    "ce:indexed-name": "Pompliano D.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Meek",
                                    "ce:indexed-name": "Meek T.D."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Drug Discov."
                        },
                        "ce:source-text": "Copeland, R.A., D.L. Pompliano, and T.D. Meek, Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug Discov., 2006. 5(9): p. 730-739."
                    },
                    {
                        "ref-fulltext": "Kwak, E.L., et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc. Natl. Acad. Sci. USA 102:21 (2005), 7665\u20137670.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "21144439000",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "102",
                                    "@issue": "21"
                                },
                                "pagerange": {
                                    "@first": "7665",
                                    "@last": "7670"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Kwak",
                                    "ce:indexed-name": "Kwak E.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proc. Natl. Acad. Sci. USA"
                        },
                        "ce:source-text": "Kwak, E.L., et al., Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc. Natl. Acad. Sci. USA, 2005. 102(21): p. 7665-7670."
                    },
                    {
                        "ref-fulltext": "Yang, C., et al. Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1\u20132 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX-Lung1): a preliminary report. J. Clin. Oncol., 27(15), 2009 8062-8062.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1\u20132 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX-Lung1): a preliminary report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "75449107400",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "27",
                                "@issue": "15"
                            }},
                            "ref-text": "8062-8062",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Yang, C., et al., Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1-2 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX-Lung1): a preliminary report. J. Clin. Oncol., 2009. 27(15_suppl): p. 8062-8062."
                    },
                    {
                        "ref-fulltext": "Katakami, N., et al. LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both. J. Clin. Oncol. 31:27 (2013), 3335\u20133341.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84884618137",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "27"
                                },
                                "pagerange": {
                                    "@first": "3335",
                                    "@last": "3341"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Katakami",
                                    "ce:indexed-name": "Katakami N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Katakami, N., et al., LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both. J. Clin. Oncol., 2013. 31(27): p. 3335-3341."
                    },
                    {
                        "ref-fulltext": "Miller, V.A., et al. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol. 13:5 (2012), 528\u2013538.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84862785051",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "528",
                                    "@last": "538"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "V.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Miller",
                                    "ce:indexed-name": "Miller V.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Miller, V.A., et al., Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol., 2012. 13(5): p. 528-538."
                    },
                    {
                        "ref-fulltext": "Sequist, L.V., et al. Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non\u2013small-cell lung cancer. J. Clin. Oncol. 28:18 (2010), 3076\u20133083.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non\u2013small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib42",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77954584507",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "3076",
                                    "@last": "3083"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Sequist",
                                    "ce:indexed-name": "Sequist L.V."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Sequist, L.V., et al., Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer. J. Clin. Oncol., 2010. 28(18): p. 3076-3083."
                    },
                    {
                        "ref-fulltext": "Sakuma, Y., et al. WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. Lab. Invest. 92:3 (2012), 371\u2013383.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib43",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84857716200",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "92",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "371",
                                    "@last": "383"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Sakuma",
                                    "ce:indexed-name": "Sakuma Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lab. Invest."
                        },
                        "ce:source-text": "Sakuma, Y., et al., WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. Lab. Invest., 2012. 92(3): p. 371-383."
                    },
                    {
                        "ref-fulltext": "Walter, A.O., et al. Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov. 3:12 (2013), 1404\u20131415.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib44",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84887977876",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1404",
                                    "@last": "1415"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Walter",
                                    "ce:indexed-name": "Walter A.O."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov."
                        },
                        "ce:source-text": "Walter, A.O., et al., Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov., 2013. 3(12): p. 1404-1415."
                    },
                    {
                        "ref-fulltext": "Cross, D.A., et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 4:9 (2014), 1046\u20131061.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib45",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84904898065",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1046",
                                    "@last": "1061"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Cross",
                                    "ce:indexed-name": "Cross D.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov."
                        },
                        "ce:source-text": "Cross, D.A., et al., AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov., 2014. 4(9): p. 1046-1061."
                    },
                    {
                        "ref-fulltext": "Engel, J., et al. Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach. J. Med. Chem. 58:17 (2015), 6844\u20136863.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib46",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941585574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "58",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "6844",
                                    "@last": "6863"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Engel",
                                    "ce:indexed-name": "Engel J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Med. Chem."
                        },
                        "ce:source-text": "Engel, J., et al., Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach. J. Med. Chem., 2015. 58(17): p. 6844-6863."
                    },
                    {
                        "ref-fulltext": "Zhou, W., et al. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature 462:7276 (2009), 1070\u20131074.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Novel mutant-selective EGFR kinase inhibitors against EGFR T790M"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib47",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "72949092456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "462",
                                    "@issue": "7276"
                                },
                                "pagerange": {
                                    "@first": "1070",
                                    "@last": "1074"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Zhou, W., et al., Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature, 2009. 462(7276): p. 1070-1074."
                    },
                    {
                        "ref-fulltext": "Zhou, W., et al. Discovery of selective irreversible inhibitors for EGFR-T790M. Bioorg. Med. Chem. Lett. 21:2 (2011), 638\u2013643.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Discovery of selective irreversible inhibitors for EGFR-T790M"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib48",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78651260008",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "638",
                                    "@last": "643"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bioorg. Med. Chem. Lett."
                        },
                        "ce:source-text": "Zhou, W., et al., Discovery of selective irreversible inhibitors for EGFR-T790M. Bioorg. Med. Chem. Lett., 2011. 21(2): p. 638-643."
                    },
                    {
                        "ref-fulltext": "Lelais, G., et al. Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imid azol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers. J. Med. Chem. 59:14 (2016), 6671\u20136689.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imid azol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib49",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84979895476",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "59",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "6671",
                                    "@last": "6689"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Lelais",
                                    "ce:indexed-name": "Lelais G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Med. Chem."
                        },
                        "ce:source-text": "Lelais, G., et al., Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imid azol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers. J. Med. Chem., 2016. 59(14): p. 6671-6689."
                    },
                    {
                        "ref-fulltext": "Ricciuti, B., et al. Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy. Ther. Adv. med. Oncol. 9:6 (2017), 387\u2013404.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib50",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020196355",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "387",
                                    "@last": "404"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Ricciuti",
                                    "ce:indexed-name": "Ricciuti B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Adv. med. Oncol."
                        },
                        "ce:source-text": "Ricciuti, B., et al., Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy. Ther. Adv. med. Oncol., 2017. 9(6): p. 387-404."
                    },
                    {
                        "ref-fulltext": "Wu, Y.-L., et al. Postoperative chemotherapy use and outcomes from ADAURA: osimertinib as adjuvant therapy for resected EGFR-mutated NSCLC. J. Thorac. Oncol. 17:3 (2022), 423\u2013433.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Postoperative chemotherapy use and outcomes from ADAURA: osimertinib as adjuvant therapy for resected EGFR-mutated NSCLC"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib51",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114022603",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "423",
                                    "@last": "433"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.-L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu Y.-L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Wu, Y.-L., et al., Postoperative chemotherapy use and outcomes from ADAURA: osimertinib as adjuvant therapy for resected EGFR-mutated NSCLC. J. Thorac. Oncol., 2022. 17(3): p. 423-433."
                    },
                    {
                        "ref-fulltext": "Eberlein, C.A., et al. Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models. Cancer Res. 75:12 (2015), 2489\u20132500.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib52",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941787370",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "75",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2489",
                                    "@last": "2500"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Eberlein",
                                    "ce:indexed-name": "Eberlein C.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Eberlein, C.A., et al., Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models. Cancer Res., 2015. 75(12): p. 2489-2500."
                    },
                    {
                        "ref-fulltext": "Stamos, J., Sliwkowski, M.X., Eigenbrot, C., Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:48 (2002), 46265\u201346272.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib53",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0141599428",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "277",
                                    "@issue": "48"
                                },
                                "pagerange": {
                                    "@first": "46265",
                                    "@last": "46272"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stamos",
                                    "ce:indexed-name": "Stamos J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Sliwkowski",
                                    "ce:indexed-name": "Sliwkowski M.X."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Eigenbrot",
                                    "ce:indexed-name": "Eigenbrot C."
                                }
                            ]},
                            "ref-sourcetitle": "J. Biol. Chem."
                        },
                        "ce:source-text": "Stamos, J., M.X. Sliwkowski, and C. Eigenbrot, Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem., 2002. 277(48): p. 46265-46272."
                    },
                    {
                        "ref-fulltext": "Gajiwala, K.S., et al. Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure 21:2 (2013), 209\u2013219.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib54",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84873406911",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "219"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Gajiwala",
                                    "ce:indexed-name": "Gajiwala K.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Structure"
                        },
                        "ce:source-text": "Gajiwala, K.S., et al., Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure, 2013. 21(2): p. 209-219."
                    },
                    {
                        "ref-fulltext": "Kashima, K., et al. CH7233163 Overcomes Osimertinib Resistant EGFR-Del19/T790M/C797S Mutation. 2020, Mol Cancer Ther.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "CH7233163 Overcomes Osimertinib Resistant EGFR-Del19/T790M/C797S Mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib55",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85133425788",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Mol Cancer Ther",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kashima",
                                    "ce:indexed-name": "Kashima K."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Kashima, K., et al., CH7233163 Overcomes Osimertinib Resistant EGFR-Del19/T790M/C797S Mutation. Mol Cancer Ther, 2020."
                    },
                    {
                        "ref-fulltext": "Csizmadia, P., MarvinSketch and MarvinView: Molecule Applets for the World Wide Web. 1999.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "MarvinSketch and MarvinView: Molecule Applets for the World Wide Web"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib56",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0348059194",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "ce:surname": "Csizmadia",
                                "ce:indexed-name": "Csizmadia P."
                            }]}
                        },
                        "ce:source-text": "Csizmadia, P., MarvinSketch and MarvinView: Molecule Applets for the World Wide Web. 1999."
                    },
                    {
                        "ref-fulltext": "Ten Brink, T., Exner, T.E., pK a based protonation states and microspecies for protein\u2013ligand docking. J. Comput. Aided Mol. Des. 24:11 (2010), 935\u2013942.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "pK a based protonation states and microspecies for protein\u2013ligand docking"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib57",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78149410394",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "935",
                                    "@last": "942"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Ten Brink",
                                    "ce:indexed-name": "Ten Brink T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Exner",
                                    "ce:indexed-name": "Exner T.E."
                                }
                            ]},
                            "ref-sourcetitle": "J. Comput. Aided Mol. Des."
                        },
                        "ce:source-text": "Ten Brink, T. and T.E. Exner, pK a based protonation states and microspecies for protein-ligand docking. J. Comput. Aided Mol. Des., 2010. 24(11): p. 935-942."
                    },
                    {
                        "ref-fulltext": "Wang, N., et al. Involvement of Nrf2 and Keap1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent peptides from soft-shelled turtle. Process Biochem. 92 (2020), 174\u2013181.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Involvement of Nrf2 and Keap1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent peptides from soft-shelled turtle"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib58",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078595317",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "92"},
                                "pagerange": {
                                    "@first": "174",
                                    "@last": "181"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Process Biochem."
                        },
                        "ce:source-text": "Wang, N., et al., Involvement of Nrf2 and Keap1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent peptides from soft-shelled turtle. Process Biochem., 2020. 92: p. 174-181."
                    },
                    {
                        "ref-fulltext": "Gotz, A.W., et al. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J. Chem. Theor. Comput. 8:5 (2012), 1542\u20131555.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib59",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84860767348",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1542",
                                    "@last": "1555"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Gotz",
                                    "ce:indexed-name": "Gotz A.W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Chem. Theor. Comput."
                        },
                        "ce:source-text": "Gotz, A.W., et al., Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J. Chem. Theor. Comput., 2012. 8(5): p. 1542-1555."
                    },
                    {
                        "ref-fulltext": "Mahalapbutr, P., Kongtaworn, N., Rungrotmongkol, T., Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2\u2032-O-Methyltransferase. Comput. Struct. Biotechnol. J. 18 (2020), 2757\u20132765.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2\u2032-O-Methyltransferase"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib60",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092287004",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2757",
                                    "@last": "2765"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahalapbutr",
                                    "ce:indexed-name": "Mahalapbutr P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Kongtaworn",
                                    "ce:indexed-name": "Kongtaworn N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Rungrotmongkol",
                                    "ce:indexed-name": "Rungrotmongkol T."
                                }
                            ]},
                            "ref-sourcetitle": "Comput. Struct. Biotechnol. J."
                        },
                        "ce:source-text": "Mahalapbutr, P., N. Kongtaworn, and T. Rungrotmongkol, Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2\u2032-O-Methyltransferase. Comput. Struct. Biotechnol. J., 2020. 18: p. 2757-2765."
                    },
                    {
                        "ref-fulltext": "Mahalapbutr, P., et al. Butoxy Mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: combined experimental and theoretical investigations. Cancers, 11(4), 2019, 437.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Butoxy Mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: combined experimental and theoretical investigations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib61",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065339809",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "4"
                                },
                                "pagerange": {"@first": "437"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahalapbutr",
                                    "ce:indexed-name": "Mahalapbutr P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers"
                        },
                        "ce:source-text": "Mahalapbutr, P., et al., Butoxy Mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: combined experimental and theoretical investigations. Cancers, 2019. 11(4): p. 437."
                    },
                    {
                        "ref-fulltext": "Soe, H.M.H., et al. The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state. Carbohydr. Res., 498, 2020, 108190.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib62",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "108190",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85095443080",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "498"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.M.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Soe",
                                    "ce:indexed-name": "Soe H.M.H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Carbohydr. Res."
                        },
                        "ce:source-text": "Soe, H.M.H., et al., The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state. Carbohydr. Res., 2020. 498: p. 108190."
                    },
                    {
                        "ref-fulltext": "Somboon, T., et al. Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease. J. Mol. Liq., 322, 2021, 114999.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib63",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "114999",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85097719516",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "322"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Somboon",
                                    "ce:indexed-name": "Somboon T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Mol. Liq."
                        },
                        "ce:source-text": "Somboon, T., et al., Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease. J. Mol. Liq., 2021. 322: p. 114999."
                    },
                    {
                        "ref-fulltext": "Maier, J.A., et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theor. Comput. 11:8 (2015), 3696\u20133713.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib64",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84938930908",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "3696",
                                    "@last": "3713"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Maier",
                                    "ce:indexed-name": "Maier J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Chem. Theor. Comput."
                        },
                        "ce:source-text": "Maier, J.A., et al., ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theor. Comput., 2015. 11(8): p. 3696-3713."
                    },
                    {
                        "ref-fulltext": "Wang, J., et al. Development and testing of a general amber force field. J. Comput. Chem. 25:9 (2004), 1157\u20131174.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Development and testing of a general amber force field"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib65",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2942532422",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1157",
                                    "@last": "1174"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Comput. Chem."
                        },
                        "ce:source-text": "Wang, J., et al., Development and testing of a general amber force field. J. Comput. Chem., 2004. 25(9): p. 1157-1174."
                    },
                    {
                        "ref-fulltext": "Frisch, A., Gaussian 09w Reference, vol. 25p, 2009 Wallingford, USA.",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib66",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85133487878",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "vol. 25p"}},
                            "ref-text": "Wallingford, USA",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Frisch",
                                "ce:indexed-name": "Frisch A."
                            }]},
                            "ref-sourcetitle": "Gaussian 09w Reference"
                        },
                        "ce:source-text": "Frisch, A., Gaussian 09w Reference. Wallingford, USA, vol. 25p, 2009."
                    },
                    {
                        "ref-fulltext": "Mahalapbutr, P., Lee, V.S., Rungrotmongkol, T., Binding hotspot and activation mechanism of maltitol and lactitol toward the human sweet taste receptor. J. Agric. Food Chem. 68:30 (2020), 7974\u20137983.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Binding hotspot and activation mechanism of maltitol and lactitol toward the human sweet taste receptor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib67",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089612313",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "30"
                                },
                                "pagerange": {
                                    "@first": "7974",
                                    "@last": "7983"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahalapbutr",
                                    "ce:indexed-name": "Mahalapbutr P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee V.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Rungrotmongkol",
                                    "ce:indexed-name": "Rungrotmongkol T."
                                }
                            ]},
                            "ref-sourcetitle": "J. Agric. Food Chem."
                        },
                        "ce:source-text": "Mahalapbutr, P., V.S. Lee, and T. Rungrotmongkol, Binding hotspot and activation mechanism of maltitol and lactitol toward the human sweet taste receptor. J. Agric. Food Chem., 2020. 68(30): p. 7974-7983."
                    },
                    {
                        "ref-fulltext": "Mahalapbutr, P., et al. Rosmarinic acid as a potent influenza neuraminidase inhibitor: in vitro and in silico study. Curr. Top. Med. Chem. 20:23 (2020), 2046\u20132055.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Rosmarinic acid as a potent influenza neuraminidase inhibitor: in vitro and in silico study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib68",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092267590",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2046",
                                    "@last": "2055"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahalapbutr",
                                    "ce:indexed-name": "Mahalapbutr P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr. Top. Med. Chem."
                        },
                        "ce:source-text": "Mahalapbutr, P., et al., Rosmarinic acid as a potent influenza neuraminidase inhibitor: in vitro and in silico study. Curr. Top. Med. Chem., 2020. 20(23): p. 2046-2055."
                    },
                    {
                        "ref-fulltext": "Ryckaert, J.-P., Ciccotti, G., Berendsen, H.J., Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:3 (1977), 327\u2013341.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1977"},
                            "ref-title": {"ref-titletext": "Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib69",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33646940952",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "327",
                                    "@last": "341"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.-P.",
                                    "@_fa": "true",
                                    "ce:surname": "Ryckaert",
                                    "ce:indexed-name": "Ryckaert J.-P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Ciccotti",
                                    "ce:indexed-name": "Ciccotti G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Berendsen",
                                    "ce:indexed-name": "Berendsen H.J."
                                }
                            ]},
                            "ref-sourcetitle": "J. Comput. Phys."
                        },
                        "ce:source-text": "Ryckaert, J.-P., G. Ciccotti, and H.J. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys., 1977. 23(3): p. 327-341."
                    },
                    {
                        "ref-fulltext": "Jorgensen, W.L., et al. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:2 (1983), 926\u2013935.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1983"},
                            "ref-title": {"ref-titletext": "Comparison of simple potential functions for simulating liquid water"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib70",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0004016501",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "79",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "926",
                                    "@last": "935"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Jorgensen",
                                    "ce:indexed-name": "Jorgensen W.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Chem. Phys."
                        },
                        "ce:source-text": "Jorgensen, W.L., et al., Comparison of simple potential functions for simulating liquid water. J. Chem. Phys., 1983. 79(2): p. 926-935."
                    },
                    {
                        "ref-fulltext": "York, D.M., Darden, T.A., Pedersen, L.G., The effect of long-range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods. J. Chem. Phys. 99:10 (1993), 8345\u20138348.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1993"},
                            "ref-title": {"ref-titletext": "The effect of long-range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib71",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "36449007976",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "99",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "8345",
                                    "@last": "8348"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.M.",
                                    "@_fa": "true",
                                    "ce:surname": "York",
                                    "ce:indexed-name": "York D.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Darden",
                                    "ce:indexed-name": "Darden T.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Pedersen",
                                    "ce:indexed-name": "Pedersen L.G."
                                }
                            ]},
                            "ref-sourcetitle": "J. Chem. Phys."
                        },
                        "ce:source-text": "York, D.M., T.A. Darden, and L.G. Pedersen, The effect of long-range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods. J. Chem. Phys., 1993. 99(10): p. 8345-8348."
                    },
                    {
                        "ref-fulltext": "Roe, D.R., Cheatham, T.E. III, PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theor. Comput. 9:7 (2013), 3084\u20133095.",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib72",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880022273",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "3084",
                                    "@last": "3095"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Roe",
                                    "ce:indexed-name": "Roe D.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheatham",
                                    "ce:suffix": "III",
                                    "ce:indexed-name": "Cheatham T.E."
                                }
                            ]},
                            "ref-sourcetitle": "J. Chem. Theor. Comput."
                        },
                        "ce:source-text": "Roe, D.R. and T.E. Cheatham III, PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theor. Comput., 2013. 9(7): p. 3084-3095."
                    },
                    {
                        "ref-fulltext": "Bakan, A., Meireles, L.M., Bahar, I., ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 27:11 (2011), 1575\u20131577.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "ProDy: protein dynamics inferred from theory and experiments"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib73",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79957788878",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1575",
                                    "@last": "1577"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bakan",
                                    "ce:indexed-name": "Bakan A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Meireles",
                                    "ce:indexed-name": "Meireles L.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Bahar",
                                    "ce:indexed-name": "Bahar I."
                                }
                            ]},
                            "ref-sourcetitle": "Bioinformatics"
                        },
                        "ce:source-text": "Bakan, A., L.M. Meireles, and I. Bahar, ProDy: protein dynamics inferred from theory and experiments. Bioinformatics, 2011. 27(11): p. 1575-1577."
                    },
                    {
                        "ref-fulltext": "Miller, B.R. III, et al. MMPBSA. py: an efficient program for end-state free energy calculations. J. Chem. Theor. Comput. 8:9 (2012), 3314\u20133321.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "MMPBSA. py: an efficient program for end-state free energy calculations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib74",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866167816",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "3314",
                                    "@last": "3321"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Miller",
                                    "ce:suffix": "III",
                                    "ce:indexed-name": "Miller B.R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Chem. Theor. Comput."
                        },
                        "ce:source-text": "Miller III, B.R., et al., MMPBSA. py: an efficient program for end-state free energy calculations. J. Chem. Theor. Comput., 2012. 8(9): p. 3314-3321."
                    },
                    {
                        "ref-fulltext": "Zhang, Y., et al. How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin a enantiomers based on molecular dynamics. ACS Chem. Neurosci. 10:5 (2019), 2467\u20132480.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin a enantiomers based on molecular dynamics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib75",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065903014",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "2467",
                                    "@last": "2480"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ACS Chem. Neurosci."
                        },
                        "ce:source-text": "Zhang, Y., et al., How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin a enantiomers based on molecular dynamics. ACS Chem. Neurosci., 2019. 10(5): p. 2467-2480."
                    },
                    {
                        "ref-fulltext": "Fu, T.-t., et al. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacol. Sin. 42:8 (2021), 1354\u20131367.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib76",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85094181994",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1354",
                                    "@last": "1367"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.-T.",
                                    "@_fa": "true",
                                    "ce:surname": "Fu",
                                    "ce:indexed-name": "Fu T.-T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Acta Pharmacol. Sin."
                        },
                        "ce:source-text": "Fu, T.-t., et al., Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacol. Sin., 2021. 42(8): p. 1354-1367."
                    },
                    {
                        "ref-fulltext": "Xue, W., et al. What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation. ACS Chem. Neurosci. 9:5 (2018), 1128\u20131140.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib77",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042768508",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1128",
                                    "@last": "1140"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Xue",
                                    "ce:indexed-name": "Xue W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ACS Chem. Neurosci."
                        },
                        "ce:source-text": "Xue, W., et al., What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation. ACS Chem. Neurosci., 2018. 9(5): p. 1128-1140."
                    },
                    {
                        "ref-fulltext": "Aiebchun, T., et al. Identification of vinyl sulfone derivatives as EGFR tyrosine kinase inhibitor: in vitro and in silico studies. Molecules, 26(8), 2021.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Identification of vinyl sulfone derivatives as EGFR tyrosine kinase inhibitor: in vitro and in silico studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib78",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85105164646",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "26",
                                "@issue": "8"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Aiebchun",
                                    "ce:indexed-name": "Aiebchun T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Molecules"
                        },
                        "ce:source-text": "Aiebchun, T., et al., Identification of vinyl sulfone derivatives as EGFR tyrosine kinase inhibitor: in vitro and in silico studies. Molecules, 2021. 26(8)."
                    },
                    {
                        "ref-fulltext": "Bello, M., et al. Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2. Int. J. Biol. Macromol. 111 (2018), 569\u2013586.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib79",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041404479",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "569",
                                    "@last": "586"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Bello",
                                    "ce:indexed-name": "Bello M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int. J. Biol. Macromol."
                        },
                        "ce:source-text": "Bello, M., et al., Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2. Int. J. Biol. Macromol., 2018. 111: p. 569-586."
                    },
                    {
                        "ref-fulltext": "Kou, S.-B., et al. Evaluation of the binding behavior of olmutinib (HM61713) with model transport protein: insights from spectroscopic and molecular docking studies. J. Mol. Struct., 1224, 2021, 129024.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Evaluation of the binding behavior of olmutinib (HM61713) with model transport protein: insights from spectroscopic and molecular docking studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib80",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "129024",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85089199268",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "1224"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.-B.",
                                    "@_fa": "true",
                                    "ce:surname": "Kou",
                                    "ce:indexed-name": "Kou S.-B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Mol. Struct."
                        },
                        "ce:source-text": "Kou, S.-B., et al., Evaluation of the binding behavior of olmutinib (HM61713) with model transport protein: insights from spectroscopic and molecular docking studies. J. Mol. Struct., 2021. 1224: p. 129024."
                    },
                    {
                        "ref-fulltext": "Zhang, H.-x., Xiong, H.-x., Li, L.-w., Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method. Spectrochim. Acta Mol. Biomol. Spectrosc. 161 (2016), 88\u201394.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib81",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84960100344",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "161"},
                                "pagerange": {
                                    "@first": "88",
                                    "@last": "94"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.-X.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang H.-X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.-X.",
                                    "@_fa": "true",
                                    "ce:surname": "Xiong",
                                    "ce:indexed-name": "Xiong H.-X."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.-W.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li L.-W."
                                }
                            ]},
                            "ref-sourcetitle": "Spectrochim. Acta Mol. Biomol. Spectrosc."
                        },
                        "ce:source-text": "Zhang, H.-x., H.-x. Xiong, and L.-w. Li, Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method. Spectrochim. Acta Mol. Biomol. Spectrosc., 2016. 161: p. 88-94."
                    },
                    {
                        "ref-fulltext": "Niho, S., et al. First-line single agent treatment with gefitinib in patients with advanced non\u2013small-cell lung cancer: a phase II study. J. Clin. Oncol. 24:1 (2006), 64\u201369.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "First-line single agent treatment with gefitinib in patients with advanced non\u2013small-cell lung cancer: a phase II study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib82",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33644845421",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "69"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Niho",
                                    "ce:indexed-name": "Niho S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Niho, S., et al., First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study. J. Clin. Oncol., 2006. 24(1): p. 64-69."
                    },
                    {
                        "ref-fulltext": "Polychronidou, G., Papakotoulas, P., Long-term treatment with erlotinib for EGFR wild-type non-small cell lung cancer: a case report. Case Rep. Oncol. 6:1 (2013), 189\u2013196.",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Long-term treatment with erlotinib for EGFR wild-type non-small cell lung cancer: a case report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib83",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84877938481",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "189",
                                    "@last": "196"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Polychronidou",
                                    "ce:indexed-name": "Polychronidou G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Papakotoulas",
                                    "ce:indexed-name": "Papakotoulas P."
                                }
                            ]},
                            "ref-sourcetitle": "Case Rep. Oncol."
                        },
                        "ce:source-text": "Polychronidou, G. and P. Papakotoulas, Long-term treatment with erlotinib for EGFR wild-type non-small cell lung cancer: a case report. Case Rep. Oncol., 2013. 6(1): p. 189-196."
                    },
                    {
                        "ref-fulltext": "Soria, J.-C., et al. Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer. N. Engl. J. Med. 378:2 (2018), 113\u2013125.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib84",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040652883",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "378",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "113",
                                    "@last": "125"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.-C.",
                                    "@_fa": "true",
                                    "ce:surname": "Soria",
                                    "ce:indexed-name": "Soria J.-C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Soria, J.-C., et al., Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N. Engl. J. Med., 2018. 378(2): p. 113-125."
                    },
                    {
                        "ref-fulltext": "Lazzari, C., Gregorc, V., Santarpia, M., Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy. J. Thorac. Dis., 11(11), 2019, 4400.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib85",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077125783",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "11"
                                },
                                "pagerange": {"@first": "4400"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Lazzari",
                                    "ce:indexed-name": "Lazzari C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Gregorc",
                                    "ce:indexed-name": "Gregorc V."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Santarpia",
                                    "ce:indexed-name": "Santarpia M."
                                }
                            ]},
                            "ref-sourcetitle": "J. Thorac. Dis."
                        },
                        "ce:source-text": "Lazzari, C., V. Gregorc, and M. Santarpia, Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy. J. Thorac. Dis., 2019. 11(11): p. 4400."
                    },
                    {
                        "ref-fulltext": "Sun, H., Wu, Y., Osimertinib in first line setting: preventive or delayed T790M occurrence?. Transl. Lung Cancer Res., 7(Suppl 3), 2018, S187.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Osimertinib in first line setting: preventive or delayed T790M occurrence?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib86",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054472069",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "S187"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Sun",
                                    "ce:indexed-name": "Sun H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu Y."
                                }
                            ]},
                            "ref-sourcetitle": "Transl. Lung Cancer Res."
                        },
                        "ce:source-text": "Sun, H. and Y. Wu, Osimertinib in first line setting: preventive or delayed T790M occurrence? Transl. Lung Cancer Res., 2018. 7(Suppl 3): p. S187."
                    },
                    {
                        "ref-fulltext": "Gourraud, P.-A., et al. Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis. J. Invest. Dermatol. 132:9 (2012), 2171\u20132175.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib87",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84865343757",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "132",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "2171",
                                    "@last": "2175"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.-A.",
                                    "@_fa": "true",
                                    "ce:surname": "Gourraud",
                                    "ce:indexed-name": "Gourraud P.-A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Invest. Dermatol."
                        },
                        "ce:source-text": "Gourraud, P.-A., et al., Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis. J. Invest. Dermatol., 2012. 132(9): p. 2171-2175."
                    },
                    {
                        "ref-fulltext": "Scherber, R., et al. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood. J. Am. Soc. Hematol. 118:2 (2011), 401\u2013408.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib88",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79960437973",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "118",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "401",
                                    "@last": "408"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Scherber",
                                    "ce:indexed-name": "Scherber R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Am. Soc. Hematol."
                        },
                        "ce:source-text": "Scherber, R., et al., The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood, J. Am. Soc. Hematol., 2011. 118(2): p. 401-408."
                    },
                    {
                        "ref-fulltext": "Akoglu, H., User's guide to correlation coefficients. Turk. J. Emerg. Med. 18:3 (2018), 91\u201393.",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "User's guide to correlation coefficients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib89",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85051027768",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "91",
                                    "@last": "93"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "ce:surname": "Akoglu",
                                "ce:indexed-name": "Akoglu H."
                            }]},
                            "ref-sourcetitle": "Turk. J. Emerg. Med."
                        },
                        "ce:source-text": "Akoglu, H., User's guide to correlation coefficients. Turk. J. Emerg. Med., 2018. 18(3): p. 91-93."
                    },
                    {
                        "ref-fulltext": "Fabbro, D., Cowan-Jacob, S.W., Moebitz, H., Ten things you should know about protein kinases: IUPHAR R eview 14. Br. J. Pharmacol. 172:11 (2015), 2675\u20132700.",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Ten things you should know about protein kinases: IUPHAR R eview 14"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib90",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928907224",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "172",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2675",
                                    "@last": "2700"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Fabbro",
                                    "ce:indexed-name": "Fabbro D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Cowan-Jacob",
                                    "ce:indexed-name": "Cowan-Jacob S.W."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Moebitz",
                                    "ce:indexed-name": "Moebitz H."
                                }
                            ]},
                            "ref-sourcetitle": "Br. J. Pharmacol."
                        },
                        "ce:source-text": "Fabbro, D., S.W. Cowan-Jacob, and H. Moebitz, Ten things you should know about protein kinases: IUPHAR R eview 14. Br. J. Pharmacol., 2015. 172(11): p. 2675-2700."
                    },
                    {
                        "ref-fulltext": "Zhai, X., et al. Insight into the therapeutic selectivity of the irreversible EGFR tyrosine kinase inhibitor osimertinib through enzyme kinetic studies. Biochemistry 59:14 (2020), 1428\u20131441.",
                        "@id": "91",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Insight into the therapeutic selectivity of the irreversible EGFR tyrosine kinase inhibitor osimertinib through enzyme kinetic studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib91",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083544002",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "59",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "1428",
                                    "@last": "1441"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhai",
                                    "ce:indexed-name": "Zhai X."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biochemistry"
                        },
                        "ce:source-text": "Zhai, X., et al., Insight into the therapeutic selectivity of the irreversible EGFR tyrosine kinase inhibitor osimertinib through enzyme kinetic studies. Biochemistry, 2020. 59(14): p. 1428-1441."
                    },
                    {
                        "ref-fulltext": "Masuzawa, K., et al. Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations. Oncotarget, 8(62), 2017, 105479.",
                        "@id": "92",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib92",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "105479",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85036542241",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "8",
                                "@issue": "62"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Masuzawa",
                                    "ce:indexed-name": "Masuzawa K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Masuzawa, K., et al., Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations. Oncotarget, 2017. 8(62): p. 105479."
                    },
                    {
                        "ref-fulltext": "Kannan, S., Fox, S.J., Verma, C.S., Exploring gatekeeper mutations in EGFR through computer simulations. J. Chem. Inf. Model. 59:6 (2019), 2850\u20132858.",
                        "@id": "93",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Exploring gatekeeper mutations in EGFR through computer simulations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib93",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067080639",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "59",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "2850",
                                    "@last": "2858"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kannan",
                                    "ce:indexed-name": "Kannan S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Fox",
                                    "ce:indexed-name": "Fox S.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Verma",
                                    "ce:indexed-name": "Verma C.S."
                                }
                            ]},
                            "ref-sourcetitle": "J. Chem. Inf. Model."
                        },
                        "ce:source-text": "Kannan, S., S.J. Fox, and C.S. Verma, Exploring gatekeeper mutations in EGFR through computer simulations. J. Chem. Inf. Model., 2019. 59(6): p. 2850-2858."
                    },
                    {
                        "ref-fulltext": "Cai, Y., et al. Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: a case report. Medicine, 98(1), 2019.",
                        "@id": "94",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: a case report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib94",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059495619",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "98",
                                "@issue": "1"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Cai",
                                    "ce:indexed-name": "Cai Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Medicine"
                        },
                        "ce:source-text": "Cai, Y., et al., Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: a case report. Medicine, 2019. 98(1)."
                    },
                    {
                        "ref-fulltext": "Eberlein, C.A., et al. Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models. Cancer Res. 75:12 (2015), 2489\u20132500.",
                        "@id": "95",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib95",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941787370",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "75",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2489",
                                    "@last": "2500"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Eberlein",
                                    "ce:indexed-name": "Eberlein C.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Eberlein, C.A., et al., Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models. Cancer Res., 2015. 75(12): p. 2489-2500."
                    },
                    {
                        "ref-fulltext": "Robinson, D.D., Sherman, W., Farid, R., Understanding kinase selectivity through energetic analysis of binding site waters. ChemMedChem: Chem. Enabling Drug Discov. 5:4 (2010), 618\u2013627.",
                        "@id": "96",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Understanding kinase selectivity through energetic analysis of binding site waters"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib96",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77950678935",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "618",
                                    "@last": "627"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Robinson",
                                    "ce:indexed-name": "Robinson D.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Sherman",
                                    "ce:indexed-name": "Sherman W."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Farid",
                                    "ce:indexed-name": "Farid R."
                                }
                            ]},
                            "ref-sourcetitle": "ChemMedChem: Chem. Enabling Drug Discov."
                        },
                        "ce:source-text": "Robinson, D.D., W. Sherman, and R. Farid, Understanding kinase selectivity through energetic analysis of binding site waters. ChemMedChem: Chem. Enabling Drug Discov., 2010. 5(4): p. 618-627."
                    },
                    {
                        "ref-fulltext": "Valley, C.C., et al. Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Mol. Biol. Cell 26:22 (2015), 4087\u20134099.",
                        "@id": "97",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib97",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84946771788",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "4087",
                                    "@last": "4099"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Valley",
                                    "ce:indexed-name": "Valley C.C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol. Biol. Cell"
                        },
                        "ce:source-text": "Valley, C.C., et al., Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Mol. Biol. Cell, 2015. 26(22): p. 4087-4099."
                    },
                    {
                        "ref-fulltext": "Johnson, L.N., Noble, M.E., Owen, D.J., Active and inactive protein kinases: structural basis for regulation. Cell 85:2 (1996), 149\u2013158.",
                        "@id": "98",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1996"},
                            "ref-title": {"ref-titletext": "Active and inactive protein kinases: structural basis for regulation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib98",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0029993727",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "85",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "149",
                                    "@last": "158"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson L.N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Noble",
                                    "ce:indexed-name": "Noble M.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Owen",
                                    "ce:indexed-name": "Owen D.J."
                                }
                            ]},
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Johnson, L.N., M.E. Noble, and D.J. Owen, Active and inactive protein kinases: structural basis for regulation. Cell, 1996. 85(2): p. 149-158."
                    },
                    {
                        "ref-fulltext": "Rajith, B., et al. Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors. Sci. Rep. 4:1 (2014), 1\u20137.",
                        "@id": "99",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib99",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84905460091",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "7"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Rajith",
                                    "ce:indexed-name": "Rajith B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Rajith, B., et al., Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors. Sci. Rep., 2014. 4(1): p. 1-7."
                    },
                    {
                        "ref-fulltext": "Martínez-Jiménez, F., et al. Rational design of non-resistant targeted cancer therapies. Sci. Rep. 7:1 (2017), 1\u201318.",
                        "@id": "100",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Rational design of non-resistant targeted cancer therapies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib100",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85032638174",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Martínez-Jiménez",
                                    "ce:indexed-name": "Martinez-Jimenez F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Martinez-Jimenez, F., et al., Rational design of non-resistant targeted cancer therapies. Sci. Rep., 2017. 7(1): p. 1-18."
                    },
                    {
                        "ref-fulltext": "Stamos, J., Sliwkowski, M.X., Eigenbrot, C., Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:48 (2002), 46265\u201346272.",
                        "@id": "101",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib101",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0141599428",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "277",
                                    "@issue": "48"
                                },
                                "pagerange": {
                                    "@first": "46265",
                                    "@last": "46272"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stamos",
                                    "ce:indexed-name": "Stamos J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Sliwkowski",
                                    "ce:indexed-name": "Sliwkowski M.X."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Eigenbrot",
                                    "ce:indexed-name": "Eigenbrot C."
                                }
                            ]},
                            "ref-sourcetitle": "J. Biol. Chem."
                        },
                        "ce:source-text": "Stamos, J., M.X. Sliwkowski, and C. Eigenbrot, Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem., 2002. 277(48): p. 46265-46272."
                    },
                    {
                        "ref-fulltext": "Wu, P., Nielsen, T.E., Clausen, M.H., FDA-approved small-molecule kinase inhibitors. Trends Pharmacol. Sci. 36:7 (2015), 422\u2013439.",
                        "@id": "102",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "FDA-approved small-molecule kinase inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib102",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84933181941",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "422",
                                    "@last": "439"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Nielsen",
                                    "ce:indexed-name": "Nielsen T.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Clausen",
                                    "ce:indexed-name": "Clausen M.H."
                                }
                            ]},
                            "ref-sourcetitle": "Trends Pharmacol. Sci."
                        },
                        "ce:source-text": "Wu, P., T.E. Nielsen, and M.H. Clausen, FDA-approved small-molecule kinase inhibitors. Trends Pharmacol. Sci., 2015. 36(7): p. 422-439."
                    },
                    {
                        "ref-fulltext": "Yonesaka, K., et al. Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFRmutant Ba/F3 cells. Oncol. Rep. 41:2 (2019), 1059\u20131066.",
                        "@id": "103",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFRmutant Ba/F3 cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib103",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058873162",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "1059",
                                    "@last": "1066"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Yonesaka",
                                    "ce:indexed-name": "Yonesaka K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol. Rep."
                        },
                        "ce:source-text": "Yonesaka, K., et al., Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFRmutant Ba/F3 cells. Oncol. Rep., 2019. 41(2): p. 1059-1066."
                    },
                    {
                        "ref-fulltext": "Scott, L.J., Osimertinib as first-line therapy in advanced NSCLC: a profile of its use. Drugs Ther. Perspect. 34:8 (2018), 351\u2013357.",
                        "@id": "104",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Osimertinib as first-line therapy in advanced NSCLC: a profile of its use"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib104",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050294086",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "34",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "351",
                                    "@last": "357"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.J.",
                                "@_fa": "true",
                                "ce:surname": "Scott",
                                "ce:indexed-name": "Scott L.J."
                            }]},
                            "ref-sourcetitle": "Drugs Ther. Perspect."
                        },
                        "ce:source-text": "Scott, L.J., Osimertinib as first-line therapy in advanced NSCLC: a profile of its use. Drugs Ther. Perspect., 2018. 34(8): p. 351-357."
                    },
                    {
                        "ref-fulltext": "Papaleo, E., et al. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J. Mol. Graph. Model. 27:8 (2009), 889\u2013899.",
                        "@id": "105",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib105",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67349196001",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "889",
                                    "@last": "899"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Papaleo",
                                    "ce:indexed-name": "Papaleo E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Mol. Graph. Model."
                        },
                        "ce:source-text": "Papaleo, E., et al., Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J. Mol. Graph. Model., 2009. 27(8): p. 889-899."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Thonburi",
            "@id": "60008786",
            "affilname": "King Mongkut's University of Technology Thonburi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008786",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85133449449",
        "dc:description": "Mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR), including L858R/T790M double and L858R/T790M/C797S triple mutations, are major causes of acquired resistance towards EGFR targeted drugs. In this work, a combination of comprehensive molecular modeling and in vitro kinase inhibition assay was used to unravel the mutational effects of EGFR on the susceptibility of three generations of EGFR tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib, dacomitinib, and osimertinib) in comparison with the wild-type EGFR. The binding affinity of all studied inhibitors towards the double and triple EGFR mutations was in good agreement with the experimental data, ranked in the order of osimertinib > afatinib > dacomitinib > erlotinib > gefitinib. Three hot-spot residues at the hinge region (M790, M793, and C797) were involved in the binding of osimertinib and afatinib, enhancing their inhibitory activity towards mutated EGFRs. Both double and triple EGFR mutations causing erlotinib and gefitinib resistance are mainly caused by the low number of H-bond occupations, the low number of surrounding atoms, and the high number of water molecules accessible to the enzyme active site. According to principal component analysis, the molecular complexation of osimertinib against the two mutated EGFRs was in a closed conformation, whereas that against wild-type EGFR was in an open conformation, resulting in drug resistance. This work paves the way for further design of the novel EGFR inhibitors to overcome drug resistance mechanisms.",
        "pubmed-id": "35803080",
        "prism:coverDate": "2022-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85133449449",
        "dc:creator": {"author": [{
            "ce:given-name": "Duangjai",
            "preferred-name": {
                "ce:given-name": "Duangjai",
                "ce:initials": "D.",
                "ce:surname": "Todsaporn",
                "ce:indexed-name": "Todsaporn D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Todsaporn",
            "@auid": "57734251200",
            "author-url": "https://api.elsevier.com/content/author/author_id/57734251200",
            "ce:indexed-name": "Todsaporn D."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85133449449"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133449449&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85133449449&origin=inward"
            }
        ],
        "source-id": "17957",
        "pii": "S0010482522005546",
        "citedby-count": "7",
        "prism:volume": "147",
        "subtype": "ar",
        "dc:title": "Structural dynamics and kinase inhibitory activity of three generations of tyrosine kinase inhibitors against wild-type, L858R/T790M, and L858R/T790M/C797S forms of EGFR",
        "openaccess": "1",
        "prism:issn": "18790534 00104825",
        "publishercopyright": "© 2022",
        "article-number": "105787",
        "subtypeDescription": "Article",
        "prism:publicationName": "Computers in Biology and Medicine",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.compbiomed.2022.105787",
        "dc:identifier": "SCOPUS_ID:85133449449",
        "dc:publisher": "Elsevier Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Drug-resistance",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Dynamics simulation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Epidermal growth factor receptor inhibitor",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Epidermal growth factor receptors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Erlotinib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gefitinib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Inhibitory activity",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Kinase inhibition",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Molecular dynamic simulation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Wild types",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Afatinib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Resistance, Neoplasm",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "ErbB Receptors",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Erlotinib Hydrochloride",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gefitinib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Drug resistance"
        },
        {
            "@_fa": "true",
            "$": "EGFR inhibitor"
        },
        {
            "@_fa": "true",
            "$": "Kinase inhibition"
        },
        {
            "@_fa": "true",
            "$": "Molecular dynamics simulation"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Computer Science Applications",
            "@code": "1706",
            "@abbrev": "COMP"
        },
        {
            "@_fa": "true",
            "$": "Health Informatics",
            "@code": "2718",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Duangjai",
            "preferred-name": {
                "ce:given-name": "Duangjai",
                "ce:initials": "D.",
                "ce:surname": "Todsaporn",
                "ce:indexed-name": "Todsaporn D."
            },
            "@seq": "1",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Todsaporn",
            "@auid": "57734251200",
            "author-url": "https://api.elsevier.com/content/author/author_id/57734251200",
            "ce:indexed-name": "Todsaporn D."
        },
        {
            "ce:given-name": "Panupong",
            "preferred-name": {
                "ce:given-name": "Panupong",
                "ce:initials": "P.",
                "ce:surname": "Mahalapbutr",
                "ce:indexed-name": "Mahalapbutr P."
            },
            "@seq": "2",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026046",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046"
            },
            "ce:surname": "Mahalapbutr",
            "@auid": "57196032669",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196032669",
            "ce:indexed-name": "Mahalapbutr P."
        },
        {
            "ce:given-name": "Rungtiva P.",
            "preferred-name": {
                "ce:given-name": "Rungtiva P.",
                "ce:initials": "R.P.",
                "ce:surname": "Poo-arporn",
                "ce:indexed-name": "Poo-arporn R.P."
            },
            "@seq": "3",
            "ce:initials": "R.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008786"
            },
            "ce:surname": "Poo-arporn",
            "@auid": "57191282184",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191282184",
            "ce:indexed-name": "Poo-arporn R.P."
        },
        {
            "ce:given-name": "Kiattawee",
            "preferred-name": {
                "ce:given-name": "Kiattawee",
                "ce:initials": "K.",
                "ce:surname": "Choowongkomon",
                "ce:indexed-name": "Choowongkomon K."
            },
            "@seq": "4",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021944",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944"
            },
            "ce:surname": "Choowongkomon",
            "@auid": "6506273203",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506273203",
            "ce:indexed-name": "Choowongkomon K."
        },
        {
            "ce:given-name": "Thanyada",
            "preferred-name": {
                "ce:given-name": "Thanyada",
                "ce:initials": "T.",
                "ce:surname": "Rungrotmongkol",
                "ce:indexed-name": "Rungrotmongkol T."
            },
            "@seq": "5",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Rungrotmongkol",
            "@auid": "6507384130",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507384130",
            "ce:indexed-name": "Rungrotmongkol T."
        }
    ]}
}}